- Home
- TTI vs GPCR Comparison
TTI vs GPCR Comparison
Compare TTI & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | TTI | GPCR |
|---|---|---|
| Founded | 1981 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1990 | 2023 |
Fundamental Metrics
Financial Performance| Metric | TTI | GPCR |
|---|---|---|
| Price | $11.71 | $88.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | $10.25 | ★ $97.90 |
| AVG Volume (30 Days) | ★ 2.1M | 1.2M |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7085.43 | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $618,755,000.00 | N/A |
| Revenue This Year | $5.52 | N/A |
| Revenue Next Year | $4.44 | N/A |
| P/E Ratio | $12.68 | ★ N/A |
| Revenue Growth | ★ 0.17 | N/A |
| 52 Week Low | $2.03 | $13.22 |
| 52 Week High | $11.71 | $94.90 |
Technical Indicators
Market Signals| Indicator | TTI | GPCR |
|---|---|---|
| Relative Strength Index (RSI) | 80.27 | 78.67 |
| Support Level | $9.47 | $61.99 |
| Resistance Level | $10.24 | $70.40 |
| Average True Range (ATR) | 0.49 | 4.96 |
| MACD | 0.16 | 1.26 |
| Stochastic Oscillator | 89.81 | 85.82 |
Price Performance
Historical ComparisonAbout TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.